 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
58.1 |
$ 333.39 |
-1.77 % |
$ 43.7 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 3.17 |
3.93 % |
$ 5.22 M |
Israel |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.73 |
3.04 % |
$ 8.97 B |
Australia |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 21.68 |
1.4 % |
$ 1.01 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
62.9 |
- |
- |
$ 399 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.24 |
2.17 % |
$ 453 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 24.58 |
-2.03 % |
$ 3.13 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.49 |
0.68 % |
$ 397 M |
Britain |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
164 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Celldex Therapeutics
CLDX
|
321 |
$ 33.87 |
1.62 % |
$ 2.25 B |
USA |
 |
Clearside Biomedical
CLSD
|
61.7 |
- |
- |
$ 25.3 M |
USA |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |